NEWSLETTER ISSUE 1
WINTER 2012
M o b i u s T h era p eu ti c s Dedicated to helping glaucoma surgeons and their patients Qualified Experience
CONTACT US: Mobius Therapeutics welcomes your thoughts and inquiries.Our contact information is below: ADDRESS Mobius Therapeutics™ 4041 Forest Park Avenue, St Louis, MO 63108 TELEPHONE & FAX Telephone: +1 314-615-6930; +1 877-EYE-MITO (877-393-6486) Fax: +1 314-615-6931 SIGN UP NOW Not registered? click this link to sign up now.
With more than a century of combined experience in ophthalmology, the core management team of Mobius™ brings rock solid management and unmatched strategic vision to ophthalmic surgery. Each member of the sales team holds more than 20 years of direct clinical experience in the ophthalmic surgery field. Mobius Therapeutics™ aims to serve its customers, educate allied health, and contribute to the cause of high quality, affordable vision care.
-Directions for Use: Yes -Assured Potency: Yes -Assured Dosing: Yes -Shelf Life: 24 months -"Black Box Warning" Removed: Yes -Room Temp Storage: Yes -Closed Transfer: Yes
Education As professional education is at the core of Mobius' mission, we offer access to a library of clinical and non-clinical studies only to registered ophthalmic professionals. In order to access these libraries, please log-in or sign up for an account. Member privileges for the education section will be granted and email notification sent upon review and approval.
Mitosol Mitosol® is the only FDA approved ophthalmic formulation of mitomycin. The Mitosol® Kit permits room temperature storage and an extended shelf life. Assured sterility, potency, and dosing along with closed transfer and qualified disposal reinvents mitomycin for ophthalmology. -Assuredly Sterile: Yes -Manufacturing Controls: Yes
MOBIUS THERAPEUTICS LLC, DEDICATED TO HELPING GLAUCOMA SURGEONS AND PATIENTS
About Glaucoma Glaucoma is often referred to as the ‘sneak thief ’ of vision. More than 3 million Americans have glaucoma, but less than half of these are diagnosed. Thousands lose vision every day, yet are unaware of its insidious progress. Glaucoma is incurable and vision loss is irreversible. Some 8% of people over 70 have glaucoma and it is six to eight times more prevalent among African Americans. Glaucoma is treated progressively with a wide range of therapeutic options. All are focused on reducing intraocular pressure, glaucoma's leading symptom.
http://www.mobiustherapeutics.com/